KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Debt Ratio (2016)

Vertex Pharmaceuticals has reported Debt Ratio over the past 6 years, most recently at 0.1 for Q4 2016.

  • Quarterly results put Debt Ratio at 0.1 for Q4 2016, down 12.33% from a year ago — trailing twelve months through Dec 2016 was 0.1 (down 12.33% YoY), and the annual figure for FY2016 was 0.1, down 12.33%.
  • Debt Ratio for Q4 2016 was 0.1 at Vertex Pharmaceuticals, down from 0.11 in the prior quarter.
  • Over the last five years, Debt Ratio for VRTX hit a ceiling of 0.14 in Q1 2015 and a floor of 0.1 in Q4 2016.
  • Median Debt Ratio over the past 3 years was 0.12 (2015), compared with a mean of 0.12.
  • Biggest five-year swings in Debt Ratio: dropped 1.12% in 2015 and later decreased 12.64% in 2016.
  • Vertex Pharmaceuticals' Debt Ratio stood at 0.13 in 2014, then decreased by 6.44% to 0.12 in 2015, then dropped by 12.33% to 0.1 in 2016.
  • The last three reported values for Debt Ratio were 0.1 (Q4 2016), 0.11 (Q3 2016), and 0.12 (Q2 2016) per Business Quant data.